Other possible effects include injection-site reactions, itching, rash, swelling, or changes in the skin where injections are repeated
Each pen contains 3 mL of solution
Jardiance (empagliflozin) is an FDA-approved tablet used to help control blood sugar levels in type 2 diabetes and is also used to reduce the risk of cardiovascular problems in adults with heart failure or cardiovascular disease with type 2 diabetes
This product should only be used by or under professional healthcare guidance and support *Long descriptions can be found below the reviews
For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
The study demonstrated dose-dependent GH responses without significant ACTH, cortisol, or prolactin elevation across a wide dose range in multiple species [1]